Faisal Ghiath Sukhtian - 04 Feb 2025 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Director
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Issuer symbol
OTLK
Transactions as of
04 Feb 2025
Transactions value $
$0
Form type
4
Filing time
06 Feb 2025, 16:40:17 UTC
Previous filing
03 Oct 2024
Next filing
03 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLK Stock Option (Right to Buy) Award $0 +12.3K $0.00 12.3K 04 Feb 2025 Common Stock 12.3K $1.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option shall vest in three (3) equal installments on each of March 31, 2025, June 30, 2025 and September 30, 2025, subject to the Optionholder's Continuous Service to the Issuer through such vesting date.